UM SOM: Global Ethics Education
Henry J. Silverman, MD, MA
Professor of Medicine - University of Maryland School of Medicine
Medical Degree: Johns Hopkins University, 1978
Master’s Degree (Philosophy): Georgetown University, 1995
Biography:
Dr. Silverman is Professor of Medicine at the University of Maryland School of Medicine. He is a faculty member of the Pulmonary & Critical Care Division in the Department of Medicine. In addition to his clinical career, Dr. Silverman has forged a career in the field of medical ethics and research ethics. He is chairperson of the Clinical Ethics Committee at the University of Maryland Medical System.
Dr. Silverman has been a principal investigator on more than 30 critical care trials during the last 20 years. He was the Principal Investigator on the NIH-funded Clinical Trials Network for the Treatment of Acute Respiratory Distress Syndrome. His research ethics activities have included Program Director of the Health Research Ethics Training Initiative In Egypt (HRETIE), member of Institutional Review Boards, member of Data Safety Monitoring Boards, and site surveyor for Accreditation Human Research Protection Programs
Research Ethics Activities
Educational Activities
Principal Investigator: Research Ethics Training Initiative in Egypt (HRETIE)
Research Ethics Committees
Member: Chesapeake Research Review, Inc.
Chair: Research Ethics Committee; NIH-sponsored ARDS Network Clinical Trials Groups
Member: Maryland Medical Research Institute
Data Safety Monitoring Board (DSMB)
Chair: NIH Center for Alternative Medicine Research of Arthritis at the University of Maryland School of Medicine
Member: Double-Blind Placebo Controlled, Randomized Multi-center Study of the Safety and Efficacy of TNF MAb in Patients With Septic Shock
Site Surveyor for Human Research Protection Accreditation Programs
AAHRPP: Association for the Accreditation of Human Research Protection Programs
NCQA Human Research Protection Program for the Veteran Affairs System
Published Articles:
Silverman HJ. Ethical considerations of ensuring an informed and autonomous consent in research involving critically ill patients. Amer J of Respir and Crit Care Med 1996; 154:582-86.
Silverman HJ, Hull S, Sugarman J. Degree of variability among institutional review boards on approved research practices and informed consent in the context of a multi-center clinical trial. Critical Care Medicine. 2001; 29:235-241.
Silverman HJ, Luce JM, Schwartz J.Protecting Decisionally Impaired Subjects In Research: The Need For A Multifaceted Approach. Am J Resp Crit Care Med. 2004; 169:10-14.
Miller FG, Silverman HJ. The Ethical Relevance of the Standard of Care in the Design of Clinical Trials. Am J Resp Crit Care Med. 2004; 169:562-564.
Silverman HJ, Miller FG. Control Group Selection in Critical Care Randomized Controlled Trials Evaluating Interventional Strategies: An Ethical Assessment. Crit Care Med. 2004; 32:852-857.
Silverman HJ, Druml C, Lemaire F, Nelson R. The European Union Directive and the protection of incapacitated subjects in research: an ethical analysis. Intensive Care Medicine. 2004; 9:1723-1729.
Silverman HJ, Luce JM, Lanken PN, Morris AH, Harabin AL, Oldmixon CF, Thompson BT, Bernard GR, for the NHLBI Acute Respiratory Distress Syndrome Clinical Trials Network. Recommendations for informed consent forms for critical care clinical trials. Critical Care Medicine. Crit Care med. 2005; 33:867- 82.
Silverman HJ. Enhancing research ethics capacity: implications for protection of research subjects, avoiding exploitation and achieving global health. Middle East Fertility Society Journal. 2005; 10:105-109.
Printer friendly
Email this page